Technical experts from the World Health Organisation (WHO) are due to start the next round of their review of Russia's Sputnik V vaccine against Covid-19 jointly with the European Medicines Agency on May 10, the WHO has said.

Russia is seeking WHO emergency-use listing for the vaccine developed by Gamalaya Institute. So far Covid-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have been listed — an endorsement of their safety and efficacy that helps guide countries' regulatory systems.

“Inspections for good manufacturing practices will take place from 10 May to 1st week of June,” the WHO told Reuters in reply to a query.